Grace Lutheran Communities - River Pines | |
206 N Willson Dr, Altoona, Wisconsin 54720 | |
(715) 598-7800 | |
Name | Grace Lutheran Communities - River Pines |
---|---|
Location | 206 N Willson Dr, Altoona, Wisconsin |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 50 |
Occupancy Rate | 86.8% |
Medicare ID (CCN) | 525724 |
Legal Business Name | Grace Lutheran Foundation, Inc. |
Ownership Type | Non Profit - Corporation |
NPI Number | 1952756991 |
Organization Name | GRACE LUTHERAN FOUNDATION, INC. |
Doing Business As | GRACE LUTHERAN COMMUNITIES - RIVER PINES |
Address | 206 North Willson Drive, Altoona, WI 54720 |
Phone Number | 715-832-3003 |
News Archive
As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.
New research released today provides insight into one of neuroscience's most intriguing mysteries: how the human brain learns and remembers. These studies - involving topics as diverse as musical memory, "change blindness," and attention deficit hyperactivity disorder (ADHD) - illustrate the profound influence that specific changes in either the brain's structure, function, or both, can have on human behavior.
Northwest Biotherapeutics, Inc. today announced further positive long-term follow-up data from its prior Phase I and Phase I/II clinical trials, in which patients with newly diagnosed Glioblastoma multiforme ("GBM"), the most rapid and lethal type of brain cancer, were treated with NWBT's DCVax®-Brain personalized immune therapy.
› Verified 9 days ago
NPI Number | 1982155248 |
Organization Name | THE BETHANY-ST. JOSEPH CORPORATION D/B/A PRAIRIE POINTE REHAB SUITES |
Doing Business As | PRAIRIE POINTE REHAB SUITES |
Address | 286 N. Willson Dr, Altoona, WI 54720 |
Phone Number | 715-598-7800 |
News Archive
As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.
New research released today provides insight into one of neuroscience's most intriguing mysteries: how the human brain learns and remembers. These studies - involving topics as diverse as musical memory, "change blindness," and attention deficit hyperactivity disorder (ADHD) - illustrate the profound influence that specific changes in either the brain's structure, function, or both, can have on human behavior.
Northwest Biotherapeutics, Inc. today announced further positive long-term follow-up data from its prior Phase I and Phase I/II clinical trials, in which patients with newly diagnosed Glioblastoma multiforme ("GBM"), the most rapid and lethal type of brain cancer, were treated with NWBT's DCVax®-Brain personalized immune therapy.
› Verified 9 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.
New research released today provides insight into one of neuroscience's most intriguing mysteries: how the human brain learns and remembers. These studies - involving topics as diverse as musical memory, "change blindness," and attention deficit hyperactivity disorder (ADHD) - illustrate the profound influence that specific changes in either the brain's structure, function, or both, can have on human behavior.
Northwest Biotherapeutics, Inc. today announced further positive long-term follow-up data from its prior Phase I and Phase I/II clinical trials, in which patients with newly diagnosed Glioblastoma multiforme ("GBM"), the most rapid and lethal type of brain cancer, were treated with NWBT's DCVax®-Brain personalized immune therapy.
› Verified 9 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 14.29 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.44 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 56.96 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.31 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.29 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.19 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.11 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.93 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 85.29 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 18.93 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.44 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 70.37 | 82.93 |
News Archive
As public-health officials continue to fight malaria in sub-Saharan Africa, researchers are trying to predict how climate change will impact the disease, which infected an estimated 219 million people in 2010 and is the fifth leading cause of death worldwide among children under age 5.
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.
New research released today provides insight into one of neuroscience's most intriguing mysteries: how the human brain learns and remembers. These studies - involving topics as diverse as musical memory, "change blindness," and attention deficit hyperactivity disorder (ADHD) - illustrate the profound influence that specific changes in either the brain's structure, function, or both, can have on human behavior.
Northwest Biotherapeutics, Inc. today announced further positive long-term follow-up data from its prior Phase I and Phase I/II clinical trials, in which patients with newly diagnosed Glioblastoma multiforme ("GBM"), the most rapid and lethal type of brain cancer, were treated with NWBT's DCVax®-Brain personalized immune therapy.
› Verified 9 days ago
Grace Lutheran Communities - River Pines Location: 206 N Willson Dr, Altoona, Wisconsin 54720 Phone: (715) 598-7800 | |
Grace Luth Communities-prairie Pointe Rehab Suites Location: 286 N Willson Dr, Altoona, Wisconsin 54720 Phone: (715) 598-7800 |